{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:56:29Z","timestamp":1790546189911,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.heliyon.2024.e33045","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T20:49:54Z","timestamp":1718311794000},"page":"e33045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive molecular analyses and experimental validation of CDCAs with potential implications in kidney renal papillary cell carcinoma prognosis"],"prefix":"10.1016","volume":"10","author":[{"given":"Fuping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2073-0222","authenticated-orcid":false,"given":"Jiali","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e33045_bib1","doi-asserted-by":"crossref","unstructured":"M. de Vries-Brilland, D.F. McDermott, C. Su\u00e1rez, T. Powles, M. Gross-Goupil, A. Ravaud, R. Flippot, B. Escudier, L. Albig\u00e8s, Checkpoint inhibitors in metastatic papillary renal cell carcinoma. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102228.","DOI":"10.1016\/j.ctrv.2021.102228"},{"key":"10.1016\/j.heliyon.2024.e33045_bib2","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S1470-2045(15)00515-X","article-title":"Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial","volume":"17","author":"Armstrong","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.heliyon.2024.e33045_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/jjco\/hyaa229","article-title":"Modest efficacy of nivolumab plus ipilimumab in patients with papillary renal cell carcinoma","volume":"51","author":"Tachibana","year":"2021","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e33045_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/his.13987","article-title":"Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma","volume":"76","author":"Eich","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.heliyon.2024.e33045_bib5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.tcb.2022.05.006","article-title":"Wnt signalling in cell division: from mechanisms to tissue engineering","volume":"32","author":"Habib","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e33045_bib6","first-page":"7415","article-title":"Increased cell division as a cause of human cancer","volume":"50","author":"Preston-Martin","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e33045_bib7","first-page":"60","article-title":"The Aurora kinase family in cell division and cancer","volume":"1786","author":"Vader","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.heliyon.2024.e33045_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1057198","article-title":"NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes","volume":"12","author":"Leng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e33045_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.793343","article-title":"Epigenetic and immune-cell infiltration changes in the tumor microenvironment in hepatocellular carcinoma","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e33045_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13148-016-0182-9","article-title":"Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer","volume":"8","author":"Clermont","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.heliyon.2024.e33045_bib11","article-title":"Cell division cycle-associated genes are potential immune regulators in nasopharyngeal carcinoma","volume":"12","author":"Jiang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.heliyon.2024.e33045_bib12","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41416-019-0387-8","article-title":"A novel approach to modelling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma","volume":"120","author":"Pique","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e33045_bib13","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1158\/0008-5472.CAN-19-3268","article-title":"CircFOXK2 promotes growth and Metastasis of pancreatic ductal adenocarcinoma by complexing with RNA-binding proteins and sponging MiR-942","volume":"80","author":"Wong","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e33045_bib14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/biof.1773","article-title":"CDCA7-regulated inflammatory mechanism through TLR4\/NF-kappaB signaling pathway in stomach adenocarcinoma","volume":"47","author":"Guo","year":"2021","journal-title":"Biofactors"},{"key":"10.1016\/j.heliyon.2024.e33045_bib15","first-page":"1","article-title":"CDCA3 promotes the proliferation and migration of hypopharyngeal squamous cell carcinoma cells by activating the Akt\/mTOR pathway","author":"Wu","year":"2023","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.heliyon.2024.e33045_bib16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jtho.2017.04.018","article-title":"Expression of CDCA3 is a prognostic biomarker and potential therapeutic target in non-small cell lung cancer","volume":"12","author":"Adams","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.heliyon.2024.e33045_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00432-022-04482-4","article-title":"Identification of molecular subtypes based on chromatin regulator and tumor microenvironment infiltration characterization in papillary renal cell carcinoma","volume":"149","author":"Tang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.heliyon.2024.e33045_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13073-015-0226-3","article-title":"The Cancer Genome Atlas Clinical Explorer: a web and mobile interface for identifying clinical-genomic driver associations","volume":"7","author":"Lee","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.heliyon.2024.e33045_bib19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The genotype-tissue expression (GTEx) project","volume":"45","author":"Consortium","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2024.e33045_bib20","doi-asserted-by":"crossref","first-page":"D747","DOI":"10.1093\/nar\/gkl995","article-title":"ArrayExpress--a public database of microarray experiments and gene expression profiles","volume":"35","author":"Parkinson","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e33045_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.heliyon.2024.e33045_bib22","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.heliyon.2024.e33045_bib23","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e33045_bib24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e33045_bib25","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e33045_bib26","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e33045_bib27","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/gb-2007-8-9-r183","article-title":"The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists","volume":"8","author":"Huang","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.heliyon.2024.e33045_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.heliyon.2024.e33045_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12853","article-title":"The up-regulation of NDRG1 by HIF counteracts the cancer-promoting effect of HIF in VHL-deficient clear cell renal cell carcinoma","volume":"53","author":"Zhang","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.heliyon.2024.e33045_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00000478-200203000-00001","article-title":"Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases","volume":"26","author":"Amin","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.heliyon.2024.e33045_bib31","doi-asserted-by":"crossref","first-page":"25466","DOI":"10.18632\/aging.203767","article-title":"Prognostic value of CDCA3 in kidney renal papillary cell carcinoma","volume":"13","author":"Li","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.heliyon.2024.e33045_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12894-023-01218-5","article-title":"Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Urol."},{"key":"10.1016\/j.heliyon.2024.e33045_bib33","doi-asserted-by":"crossref","first-page":"190","DOI":"10.21037\/atm.2020.01.99","article-title":"The role of the CDCA gene family in ovarian cancer","volume":"8","author":"Chen","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e33045_bib34","first-page":"64","article-title":"Multidimensional study of cell division cycle-associated proteins with prognostic value in gastric carcinoma","volume":"22","author":"Lu","year":"2022","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.heliyon.2024.e33045_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature03097","article-title":"Cell-cycle checkpoints and cancer","volume":"432","author":"Kastan","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e33045_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7150\/thno.30308","article-title":"Selective autophagy regulates cell cycle in cancer therapy","volume":"9","author":"Zheng","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.heliyon.2024.e33045_bib37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12253-018-0531-4","article-title":"Downregulation of NOP53 ribosome biogenesis factor leads to abnormal nuclear division and chromosomal instability in human cervical cancer cells","volume":"26","author":"Lee","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.heliyon.2024.e33045_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2019.04.007","article-title":"Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions","volume":"38","author":"Khan","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.heliyon.2024.e33045_bib39","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1111\/j.1349-7006.2010.01725.x","article-title":"Role of ZNF143 in tumor growth through transcriptional regulation of DNA replication and cell-cycle-associated genes","volume":"101","author":"Izumi","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.heliyon.2024.e33045_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heliyon.2024.e33045_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1189","article-title":"Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: a tumor bulk and single-cell transcriptomic study","volume":"13","author":"Zheng","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e33045_bib42","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/cas.13996","article-title":"Immune infiltration in renal cell carcinoma","volume":"110","author":"Zhang","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.heliyon.2024.e33045_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6343760","article-title":"CDCA3 predicts poor prognosis and affects CD8(+) T cell infiltration in renal cell carcinoma","volume":"2022","author":"Bai","year":"2022","journal-title":"J Oncol"},{"key":"10.1016\/j.heliyon.2024.e33045_bib44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12935-021-01834-x","article-title":"High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.heliyon.2024.e33045_bib45","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cytogfr.2021.08.001","article-title":"Role of the APRIL molecule in solid tumors","volume":"61","author":"Nowacka","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.heliyon.2024.e33045_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.heliyon.2024.e33045_bib47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/cmi.2017.143","article-title":"Ido1 in cancer: a Gemini of immune checkpoints","volume":"15","author":"Zhai","year":"2018","journal-title":"Cell. Mol. Immunol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024090765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024090765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:58:41Z","timestamp":1790542721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024090765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2405844024090765"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33045","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive molecular analyses and experimental validation of CDCAs with potential implications in kidney renal papillary cell carcinoma prognosis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e33045"}}